Organoids Explained: 5 Advantages to Benefit Your Research
Introduction In the ever-evolving field of biomedical research, the search for advanced models to study human physiology and disease has led to groundbreaking discoveries....
News & Events
From attending international conferences, to celebrating important scientific milestones, visit this hub to stay up to date with all things Epistem.
Targeted Sequencing: Unveiling Genetic Insights
Targeted sequencing, also known as gene panel sequencing, utilises NGS sequencing technology to selectively sequence a subset of genes or regions within the genome....
Epistem to attend Bio€quity Europe 2023
May 14-16, 2023 • Convention Centre Dublin Spencer Dock North Wall Quay Dublin, Ireland We are thrilled to announce our attendance at BioEquity Europe...
Epistem is Exhibiting at the Digestive Disease Week...
Epistem’s team of experts will be exhibiting at Booth 3132! We will also present some of our preclinical work in IBD. If you would like...
AACR Annual Meeting 2023 Round-up!
AACR Annual Meeting 2023 Round-up! 16th to 19th April · Orange County Convention Center, Orlando Our Oncology Experts attended the AACR Annual Meeting 2023 to...
Epistem celebrates National DNA Day
National DNA Day is a momentous occasion for the scientific community, celebrating advancements in genetic research and the discovery of the double helix structure...
Epistem to exhibit at the AACR 2023
April 16-19, 2023 Orange County Convention Center in Orlando, Florida Come and meet the Epistem Team at Booth 2464! We're excited to connect with you...
Epistem appoints new Commercial Director
Epistem, the Manchester based pre-clinical and clinical research services company announces the board appointment of Andy Edwards as Commercial Director. Andy is a skilled international manager with...
International Day of Women & Girls in Science
International Day of Women and Girls in Science is a powerful opportunity to celebrate the achievements of women in science and to promote gender...
Epistem licenses Hubrecht Organoid Technology
Epistem Limited, a UK-based pre-clinical and clinical research services company, has expanded its in vitro model portfolio through an agreement with Hubrecht Organoid Technology (HUB). The...
